InvestorsHub Logo
Post# of 24568
Next 10
Followers 88
Posts 12370
Boards Moderated 1
Alias Born 07/24/2009

Re: None

Thursday, 10/01/2009 10:22:02 PM

Thursday, October 01, 2009 10:22:02 PM

Post# of 24568
6 BIEL's FDA Applications from yhb

(1) Allay Menstrual Patch
(2) Heel/Foot Pain and Plantar Fasciitis
(3) Musculoskeletal Disorder
(4) General Surgery Recovery
(5) Diabetic Wound Care
(6) Uveitis Treatment

Summary...

(1) Allay Menstrual Patch: Dr Barry Eppley obtained a 100% safe and effective result from this study. BIEL has already submitted this application to the FDA.

(2) Heel/Foot Pain and Plantar Fasciitis: Dr David Genecov has conducted a major study on this, and BIEL will soon submit the application to the FDA.

(3) Musculoskeletal Disorder: Dr Sheena Kong is conducting this study. This is not just for heel and foot pain; it targets "general" muscle-skeletal complaints.

(4) General Surgery Recovery: This involves recovery in the areas of breast augmentation and cesarean section. Dr Barry Eppley, Dr David Genecov, and Dr Michael Lopez are conducting these studies. Also, study results from Europe are expected to be complete soon.

(5) Diabetic Wound Care: Physicians in Europe are conducting clinical studies for this treatment. BIEL is confident that the study will be successful.

(6) Uveitis Treatment: Uveitis is a type of inflammation in the eye. BIEL is currently conducting studies to determine the effective treatment of this condition using the PEMF technology.

The FDA will make decisions on BIEL's devices based on the PEMF technology. Pulsed-Electromagnetic Field (PEMF) treatment is known in the medical community to be safe and effective in treating pain and helping healing. BIEL's devices are based on the PEMF technology.

http://biomedreports.com/articles/latest...

http://finance.yahoo.com/news/BioElectro...

http://www.healthy.net/scr/Article.asp?I...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.